C40H50N8O6
Neat
738.9
+5°C
Room Temperature
Daclatasvir; 1009119-64-5; BMS-790052; BMS790052; BMS 790052; EBP 883; Carbamic acid, N, N'-[[1, 1'-biphenyl]-4, 4'-diylbis[1H-imidazole-5, 2-diyl-(2S)-2, 1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2, 1-ethanediyl]]]bis-, C, C'-dimethyl ester; methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate; EBP-883; LI2427F9CI; CHEBI:82977; Carbamic acid, N, N'-((1, 1'-biphenyl)-4, 4'-diylbis(1H-imidazole-5, 2-diyl-(2S)-2, 1-pyrrolidinediyl((1S)-1-(1-methylethyl)-2-oxo-2, 1-ethanediyl)))bis-, C, C'-dimethyl ester; daclatasvirum; DTXSID901026404; methyl N-((2S)-1-((2S)-2-(5-(4-(4-(2-((2S)-1-((2S)-2-(methoxycarbonylamino)-3-methylbutanoyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)phenyl)phenyl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate; RefChem:585147; J05AP07; DTXCID901510617; 881-759-2; Dimethyl N, N'-(biphenyl-4, 4'-diylbis(1H-imidazole-5, 2-diyl-((2S)-pyrrolidine-2, 1-diyl)((1S)-1-(1-methylethyl)-2-oxoethane-2 and 1-diyl)))dicarbamate
methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
InChI=1S/C40H50N8O6/c1-23(2)33(45-39(51)53-5)37(49)47-19-7-9-31(47)35-41-21-29(43-35)27-15-11-25(12-16-27)26-13-17-28(18-14-26)30-22-42-36(44-30)32-10-8-20-48(32)38(50)34(24(3)4)46-40(52)54-6/h11-18,21-24,31-34H,7-10,19-20H2,1-6H3,(H,41,43)(H,42,44)(H,45,51)(H,46,52)/t31-,32-,33-,34-/m0/s1